A class of drugs used for their ability to stop tumor cells from dividing is now under study for their potential to reduce the pain and damage caused by sickle cell disease, investigators report. The ...

A gene with a significant effect on regulating hemoglobin in the body has been identified as part of a genome-wide association study, which looked at the link between genes and hemoglobin level in ...

AUGUSTA, Ga. (May 11, 2023) – A class of drugs used for their ability to stop tumor cells from dividing is now under study for their potential to reduce the pain and damage caused by sickle cell ...

A Phase 1b trial shows the higher dose of pociredir boosts fetal hemoglobin levels in adults with sickle cell disease.

According to Ira Zackon, MD, a hematologist-oncologist and senior medical director at Ontada, a retrospective study of over ...

An Hgb blood test measures a person’s hemoglobin levels. This protein helps red blood cells carry oxygen and keep cells and organs functioning. Low hemoglobin is known as anemia. Hemoglobin is also ...

People with the thalassemia trait, or thalassemia carriers, may not experience any symptoms. However, some thalassemia carriers can experience anemia symptoms, such as paleness and fatigue. In people ...

Medically reviewed by Oliver Eng, MDKey TakeawaysBlood cancers like leukemia hinder the production of red blood cells, ...

What Is an MCHC Blood Test? A mean corpuscular hemoglobin concentration (MCHC) blood test measures the amount of a protein called hemoglobin in your red blood cells. It’s one of many measurements ...

Whether you inherit alpha- or beta-thalassemia depends on which genes are affected. The number of affected genes can determine the subtype of alpha- or beta-thalassemia and the severity of your ...

There are many levels at which a scientific question can be answered. An answer that is quite satisfying to a scientist from one discipline may be totally unsatisfactory to a scientist from another.

Shares of the gene-editing pioneer CRISPR Therapeutics (NASDAQ: CRSP) had already fallen by half from their peak last June, but that didn't stop a Wall Street analyst from knocking it down another peg ...